DividendInvestor℠ focuses on the activities of portfolios of Morningstar, Inc. that are invested in accordance with the Dividend Select strategy. These portfolios are managed by Morningstar Investment Management LLC, a registered investment adviser, who manages other client portfolios using these strategies.
From the DividendInvestor news file this week:
Realty Income O bumped its monthly dividend to $0.226 a share, a 0.2% increase from its previous monthly rate. Altria MO is mentioned in a new analyst note below from Morningstar Research Services about the FDA's "anti-initiation" strategy to combat youth consumption of e-cigarettes. Best wishes,
David Harrell
Editor, Morningstar DividendInvestor
News and Research for Dividend Select Portfolio Holdings
FDA Signals Anti-Initiation Strategy Will Be Sustained Under New Commissioner
by Philip Gorham, CFA, FRM | Morningstar Research Services LLC | 03-14-19
The FDA announced tighter measures against what it describes as "epidemic" levels of youth consumption of e-cigarettes, a move we think signals the FDA will continue to pursue anti-initiation policies despite the resignation of commissioner Scott Gottlieb. We are reiterating our fair value estimates for the tobacco manufacturers as the measures, while significant in terms of signaling the FDA's stance, will not have much direct impact on tobacco manufacturers' cash flows.
The FDA's proposals include a ban on flavored cigars, moving forward the application deadline for flavored e-cigarettes (except menthol, mint and tobacco) to August 2021, and new rules that would give the FDA the ability to eliminate products from the market it believes are being marketed to or sold to minors. These proposals will mostly affect Altria through its interest in Juul. They will also affect Imperial Brands and British American Tobacco, although with vaping products representing an immaterial amount of all companies' EBIT, any slowdown in sales growth is likely to have limited impact.
The FDA also plans to levy a user fee from e-cigarette manufacturers, much in the same way as it currently does to tobacco manufacturers. The proposal estimates the FDA would collect $100 million annually from such a levy. Although we have not modelled such an event into our tobacco valuations, we are not surprised at this proposal. In time, we expect the tax burden of e-cigarettes and heated tobacco units to be much heavier than normal goods, akin to current cigarette taxation. This measure, if imposed, will either shrink the price gap between e-cigarettes and more expensive tobacco products or squeeze the margins of the manufacturers if the cost is not passed through. We view the former scenario as more likely.
Investment research is produced and issued by subsidiaries of Morningstar, Inc. including, but not limited to, Morningstar Research Services LLC, registered with and governed by the U.S. Securities and Exchange Commission. Analyst ratings are subjective in nature and should not be used as the sole basis for investment decisions. Analyst ratings are based on Morningstar’s analysts’ current expectations about future events and therefore involve unknown risks and uncertainties that may cause such expectations not to occur or to differ significantly from what was expected. Analyst ratings are not guarantees nor should they be viewed as an assessment of a stock's creditworthiness. Ratings, analysis, and other analyst thoughts are provided for informational purposes only; references to securities should not be considered an offer or solicitation to buy or sell the securities.
©2019 Morningstar, Inc. All rights reserved. The Morningstar name and logo are registered marks of Morningstar, Inc. The information contained in this document is the proprietary material of Morningstar, Inc. Reproduction, transcription, or other use, by any means, in whole or in part, without the prior written consent of Morningstar, Inc., is prohibited. All data presented is based on the most recent information available to Morningstar, Inc. as of the release date and may or may not be an accurate reflection of current data. There is no assurance that the data will remain the same.
Disclosure:
The commentary, analysis, references to, and performance information contained within Morningstar® DividendInvestor℠, except where explicitly noted, reflects that of portfolios owned by Morningstar, Inc. that are invested in accordance with the Dividend Select strategy managed by Morningstar Investment Management LLC, a registered investment adviser and subsidiary of Morningstar, Inc. References to "Morningstar" refer to Morningstar, Inc.
Opinions expressed are as of the current date and are subject to change without notice. Morningstar, Inc. and Morningstar Investment Management LLC shall not be responsible for any trading decisions, damages, or other losses resulting from, or related to, the information, data, analyses or opinions or their use. This commentary is for informational purposes only and has not been tailored to suit any individual.
The information, data, analyses, and opinions presented herein do not constitute investment advice, are provided as of the date written, are provided solely for informational purposes and therefore are not an offer to buy or sell a security. Please note that references to specific securities or other investment options within this piece should not be considered an offer (as defined by the Securities and Exchange Act) to purchase or sell that specific investment.
This commentary contains certain forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially and/or substantially from any future results, performance or achievements expressed or implied by those projected in the forward-looking statements for any reason.
Investments in securities are subject to investment risk, including possible loss of principal. Prices of securities may fluctuate from time to time and may even become valueless. Securities in this report are not FDIC-insured, may lose value, and are not guaranteed by a bank or other financial institution. Before making any investment decision, investors should read and consider all the relevant investment product information. Investors should seriously consider if the investment is suitable for them by referencing their own financial position, investment objectives, and risk profile before making any investment decision. There can be no assurance that any financial strategy will be successful.
Common stocks are typically subject to greater fluctuations in market value than other asset classes as a result of factors such as a company's business performance, investor perceptions, stock market trends and general economic conditions.
All Morningstar Stock Analyst Notes were published by Morningstar, Inc. The Week in Dividends contains all Analyst Notes that relate to holdings in Morningstar, Inc.'s Dividend Select Portfolio. Morningstar’s analysts are employed by Morningstar, Inc. or its subsidiaries. In the United States, that subsidiary is Morningstar Research Services LLC, which is registered with and governed by the U.S. Securities and Exchange Commission.
|